For Immediate Release May 8, 2014 – – –
Reilly to Serve Again on DATIA Board
The Drug and Alcohol Testing Industry Association (DATIA merged with NDASA in 2023) has again elected Joe Reilly to serve on its board of directors. DATIA is a national trade organization of drug and alcohol testing providers. Reilly will be seated as a director at the upcoming Board meeting May 27, 2014 at the Arizona Biltmore Resort. This will coincide with the annual DATIA national conference to be held May 28-30, 2014 also at the Arizona Biltmore Resort and Spa – Phoenix, Arizona.
Reilly previously served as a DATIA board member from 2001 – 2009 and served as Chairman of the Board from 2004 – 2008. Under Joe’s leadership, the organization grew to over 1300 members with a balanced budget and healthy reserve account becoming the dominant industry association for the drug testing industry. The industry magazine FOCUS was launched in 2008 as one of the highlights of Joe’s four year term as Chairman.Â
With experience since 1993 in the drug and alcohol testing industry, Reilly is considered a national expert in the field of workplace drug testing. He regularly provides expert witness testimony, consulting and training programs in this field throughout the United States.  Joe stated “I am excited to again be a part of DATIA’s leadership to assist our new Chairman Phil Dubois and other board members in steering our association as the industry starts to again see rapid growth.”
Reilly holds executive positions with multiple companies in the drug and alcohol testing industry; Joe Reilly & Associates, USA Mobile Drug Testing and National Drug Screening. He works out of his offices in Melbourne, Florida residing in Indian Harbour Beach, Florida.
The Drug and Alcohol Testing Industry Association (DATIA) was founded in 1995 as the National Association of Collection Sites, and has grown to represent over 1500 members, and expanded its scope. DATIA now represents the entire spectrum of drug and alcohol service providers including collection sites, laboratories, consortiums/TPAs, MROs, and testing equipment manufacturers.    Â
For additional information please contact Julie Floriano at 866-843-4545 or julie@nationaldrugscreening.com.   Â
